Vaccinations for pregnant women

Obstetrics and Gynecology

Volumn 125, Issue 1, 2015, Pages 212-226

  Swamy, Geeta K ^a   Heine, R Phillips ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; SUBUNIT VACCINE; VACCINE;

ARTICLE; CHICKENPOX; CLINICAL PRACTICE; CONGENITAL MALFORMATION; GYNECOLOGIST; HEALTH CARE PERSONNEL; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNIZATION; INFLUENZA; LOW BIRTH WEIGHT; MEASLES; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; MUMPS; OBSTETRICIAN; PASSIVE IMMUNIZATION; PNEUMOCOCCAL INFECTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; RUBELLA; SPONTANEOUS ABORTION; TRAVEL; VACCINATION; ANIMAL; DIPHTHERIA; DRUG DEVELOPMENT; FEMALE; GYNECOLOGY; INFLUENZA, HUMAN; MENINGOCOCCAL INFECTIONS; OBSTETRICS; PATIENT ATTITUDE; PNEUMOCOCCAL INFECTIONS; PREGNANCY COMPLICATIONS, INFECTIOUS; TETANUS; WHOOPING COUGH; ZOONOSES;

ANIMALS; CHICKENPOX; DIPHTHERIA; DRUG DISCOVERY; FEMALE; GYNECOLOGY; HEPATITIS A; HEPATITIS B; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFLUENZA, HUMAN; MEASLES; MENINGOCOCCAL INFECTIONS; MUMPS; OBSTETRICS; PATIENT ACCEPTANCE OF HEALTH CARE; PNEUMOCOCCAL INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RUBELLA; TETANUS; TRAVEL; VACCINATION; VACCINES; WHOOPING COUGH; ZOONOSES;

EID: 84927778649     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000581     Document Type: Article

References (91)

1. Centers for Disease Control and Prevention. Vaccines and immunizations- vaccines and preventable diseases. Available at: http://www.cdc.gov/vaccines/vpd-vac/Retrieved March 17, 2014.
2. Centers for Disease Control and Prevention (CDC). Ten great public health achievements-United States, 2001-2010. MMWR Morb Mortal Wkly Rep 2011;60:619-23.
3. National Foundation for Infectious Diseases. Facts about adult immunization 2009. Available at: http://www.nfid.org/publications/factsheets/adultfact.pdf. Retrieved December 30, 2013.
4. U.S. Department of Health and Human Services. 2020 topics & objectives: Immunization and infectious diseases. Available at: https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases. Retrieved January 2, 2014.
5. Centers for Disease Control and Prevention (CDC). Noninfluenza vaccination coverage among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2013;62:66-72.
6. Increasing appropriate vaccination. Available at: http://www.thecommunityguide.org/vaccines/index.html Retrieved January 3, 2014.
7. Vaccines for the 21st century: A tool for decision making. Washington, DC: The National Academies Press; 2000.
8. Leader S, Perales PJ. Provision of primary-preventive health care services by obstetrician-gynecologists. Obstet Gynecol 1995;85:391-5.
9. Centers for Disease Control and Prevention (CDC). Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)-United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep 2011;60:1193-6.
10. Håberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HJ, Samuelsen SO, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013;368: 333-40.
11. Louie JK, Acosta M, Jamieson DJ, Honein MA; California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010;362:27-35.
12. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998;148: 1094-102.
13. Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M; UKOSS. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011;342:d3214.
14. Zaman K, Roy E, Arifeen SE, Rahman M, Ragib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;359:1555-64.
15. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody Protection in young infants. J Infect Dis 1993;168:647-56.
16. Edwards KM. Overview of pertussis: Focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005;24(suppl):S104-S8.
17. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among pregnant women-United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2013;62:787-92.
18. Centers for Disease Control and Prevention. Guidelines for vaccinating pregnant women. Available at: http://www.cdc.gov/vaccines/pubs/preg-guide.htm#ppsv23. Retrieved January 2, 2014.
19. The history of vaccines-different types of vaccines. Available at: http://www.historyofvaccines.org/content/articles/differenttypes-vaccines. Retrieved March 13, 2014.
20. Plotkin S, Orenstein W, Offit P. Vaccines. 6th ed. Philadelphia (PA): Saunders; 2012.
21. Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis 2008;14:95-100.
22. Cantu J, Tita AT. Management of influenza in pregnancy. Am J Perinatol 2013;30:99-103.
23. Yates L, Pierce M, Stephens S, Mill AC, Spark P, Kurinczuk JJ, et al. Influenza A/H1N1v in pregnancy: An investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess 2010;14:109-82.
24. Toback SL, Beigi R, Tennis P, Sifakis F, Calingaert B, Ambrose CS. Maternal outcomes among pregnant women receiving live attenuated influenza vaccine. Influenza Other Respir Viruses 2012;6:44-51.
25. Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vázquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010;51: 1355-61.
26. Poehling KA, Szilagyi PG, Staat MA, Snively BM, Payne DC, Bridges CB, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011;204 (suppl 1):S141-8.
27. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children- diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003-32.
28. Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Available at: http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm. Retrieved March 18, 2014.
29. Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ 2009;181:55-8.
30. Centers for Disease Control and Prevention. Notifiable diseases and mortality tables. Atlanta (GA): Centers for Disease Control & Prevention; 2014.
31. Centers for Disease Control and Prevention. Pertussis (Whooping cough) outbreaks. Available at: http://www.cdc.gov/pertussis/outbreaks/index.html. Retrieved January 3, 2014.
32. Weber C, Boursaux-Eude C, Coralie G, Caro V, Guiso N. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol 2001;39:4396-403.
33. Wendelboe AM, VanRie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24(suppl):S58-S61.
34. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003;22:628-34.
35. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega- Sanchez I, Lee GM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006;55:1-37.
36. Steiner B, Swamy GK, Walter EB. Engaging expectant parents to receive Tdap vaccination. Am J Perinatol 2014;31:407-12.
37. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012;54:78-84.
38. Centers for Disease Control and Prevention (CDC). Updated recommendations for Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and Persons who have or Anticipate having close contact with an infant aged, 12 months-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1424-6.
39. Terranella A, Asay GR, Messonnier ML, Clark TA, Liang JL. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: A decision analysis. Pediatrics 2013;131: e1748-56.
40. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62: 131-5.
41. Centers for Disease Control and Prevention. 2012 final pertussis surveillance report. 2013. Available to: http://www.cdc.gov/pertussis/downloads/pertussis-surveillance-report.pdf. Retrieved January 3, 2013.
42. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011; 204:334.e1-5.
43. Pertussis vaccine in healthy pregnant women. Available at: http://clinicaltrials.gov/show/nct00707148. Retrieved January 3, 2014.
44. Pertussis Maternal Immunization Study. Available at: http://clinicaltrials.gov/show/nct00553228 Retrieved January 3, 2014.
45. Siegel M, Fuerst HT. Low birth weight and maternal virus diseases. A prospective study of rubella, measles, mumps, chickenpox, and hepatitis. JAMA 1966;197:680-4.
46. Centers for Disease Control and Prevention (CDC). Three cases of congenital rubella syndrome in the postelimination era-Maryland, Alabama, and Illinois, 2012. MMWR Morb Mortal Wkly Rep 2013;62:226-9.
47. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998;47:1-57.
48. Centers for Disease Control and Prevention (CDC). Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb Mortal Wkly Rep 2001;50:1117.
49. Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1-40.
50. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548-51.
51. Centers for Disease Control and Prevention. Monitoring the impact of varicella vaccination. Available at: http://www.cdc.gov/chickenpox/hcp/monitoring-varicella.html. Retrieved January 3, 2014.
52. Merck pregnancy registries: varicella zoster virus-containing vaccines. Available at: http://www.merckpregnancyregistries.com/varivax.html. Retrieved January 3, 2014.
53. Perinatal viral and parasitic infections. ACOG Practice Bulletin No. 20. American College of Obstetrics and Gynecologists. Int J Gynaecol Obstet 2002;76:95-107.
54. Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1-23.
55. Centers for Disease Control and Prevention. Surveillance for viral hepatitis- United States, 2011. Available at: http://www.cdc.gov/hepatitis/Statistics/2011Surveillance/Retrieved January 3, 2014.
56. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. MMWR Recomm Rep 2006;55:1-33.
57. Viral hepatitis in pregnancy. ACOG Practice Bulletin No. 86. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:941-56.
58. Pan CQ, Lee HM. Antiviral therapy for chronic hepatitis B in pregnancy. Semin Liver Disease 2013;33:138-46.
59. Makris MC, Polyzos KA, Mavros MN, Athanasiou S, Rafailidis PI, Falagas ME. Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: A systematic review. Drug Saf 2012;35:1-14.
60. Centers for Disease Control and Prevention. Pneumococcal disease. Available at: http://www.cdc.gov/pneumococcal/index.html. Retrieved January 3, 2014.
61. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 2010;59:1102-6.
62. Munoz FM, Englund JA, Cheesman CC, Maccato ML, Pinell PM, Nahm MH, et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 2001;20:826-37.
63. Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013;62:1-28.
64. O'Dempsey TJ, McArdle T, Ceesay SJ, Secka O, Demba E, Banya WA, et al. Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy. Arch Dis Child Fetal Neonatal Ed 1996;74: F43-6.
65. Maternal flu vaccine trial in Bamako, Mali. Available at: http://clinicaltrials.gov/show/NCT01430689 Retrieved January 3, 2014.
66. Centers for Disease Control and Prevention. CDC health information for international travel. New York (NY): Oxford University Press; 2014.
67. Suzano CE, Amaral E, Sato HK, Papaiordanou PM; Campinas Group on Yellow Fever Immunization during Pregnancy. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil. Vaccine 2006;24:1421-6.
68. Staples JE, Gershman M, Fischer M, Centers for Disease Control and Prevention (CDC). Yellow fever vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2010;59:1-27.
69. Fischer M, Lindsey N, Staples JE, Hills S; Centers for Disease Control and Prevention (CDC). Japanese encephalitis vaccines: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2010;59:1-27.
70. Centers for Disease Control and Prevention. National center for emerging and zoonotic infectious diseases, typhoid fever. Available at: http://www.cdc.gov/nczved/divisions/dfbmd/diseases/typhoid-fever/. Retrieved January 3, 2014.
71. Wright JG, Quinn CP, Shadomy S, Messonnier N; Centers for Disease Control and Prevention (CDC). Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2010;59:1-30.
72. Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, et al. Human rabies prevention- United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008;57:1-28.
73. Chutivongse S, Wilde H, Benjavongkulchai M, Chomchey P, Punthawong S. Postexposure rabies vaccination during pregnancy: effect on 202 women and their infants. Clin Infect Dis 1995;20:818-20.
74. Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010;59:1-9.
75. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59: 1-36.
76. Centers for Disease Control and Prevention. Group B Strep (GBS). Available at: http://www.cdc.gov/groupbstrep/clinicaloverview.html. Retrieved January 3, 2014.
77. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: A multistate, population-based analysis. Pediatr Infect Dis J 2008;27:1057-64.
78. Immune response induced by a vaccine against group B Streptococcus and safety in pregnant women and their off springs. Available at: http://clinicaltrials.gov/show/NCT01446289. Retrieved January 2, 2014.
79. Centers for Disease Control and Prevention. RSV trends and surveillance. Available at: http://www.cdc.gov/rsv/research/us-surveillance.html. Retrieved January 2, 2014.
80. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969;89:422-34.
81. Safety study of respiratory syncytial virus (RSV)-fusion (F) protein particle vaccine. Available at: http://clinicaltrials.gov/show/NCT01290419. Retrieved January 2, 2014.
82. Leddy MA, Anderson BL, Power ML, Gall S, Gonik B, Schulkin J. Changes in and current status of obstetrician-gynecologists' knowledge, attitudes, and practice regarding immunization. Obstet Gynecol Surv 2009;64:823-9.
83. Panda B, Stiller R, Panda A. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. J Matern Fetal Neonatal Med 2011;24:402-6.
84. Ahluwalia IB, Jamieson DJ, Rasmussen SA, D'Angelo D, Goodman D, Kim H. Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol 2010;116:949-55.
85. Influenza vaccination during pregnancy. Committee Opinion No. 608. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014;124:648-51.
86. Shavell VI, Moniz MH, Gonik B, Beigi RH. Influenza immunization in pregnancy: overcoming patient and health care provider barriers. Am J Obstet Gynecol 2012;207 (suppl):S67-S74.
87. Immunization for women: Immunization information for ob-gyns and their patients. Available at: http://www.immunizationforwomen.org/Retrieved 2013.
88. American Academy of Pediatrics. Vaccine safety: examine the evidence. 2013. Available at: http://www2.aap.org/immunization/families/faq/VaccineStudies.pdf. Retrieved December 27, 2013.
89. Immunization Action Coalition. Evidence shows vaccines unrelated to autism. Available at: http://www.immunize.org/catg.d/p4028.pdf. Retrieved January 3, 2014.
90. Vaccine Adverse Event Reporting System (VAERS). Available at: https://vaers.hhs.gov/index. Retrieved January 3, 2014.
91. Vaccine safety, CISA evaluation. Available at: http://www.cdc.gov/vaccinesafety/Activities/cisa/cisa-evaluation.html. Retrieved January 3, 2014.